Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...
A study finds permissive lab screening thresholds double primary aldosteronism detection rates versus Endocrine Society ...
Biodesix, in partnership with Bio-Rad and Thermo Fisher Scientific, advances tumor-informed and tumor-naïve MRD assays for ...
Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.
Biodesix Partners With Vanderbilt to Develop Lung Cancer Risk Test Combining Blood Tests and Imaging
Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.
WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...
Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.
Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...
A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...
Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...
Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...
A peer-reviewed study validates Gnosis' EdenDx cervical sample test, showing 96.8% specificity for endometrial cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results